Mankind Pharma Expands CNS Portfolio with Rivotril Acquisition; Shares Rise Over 2%
Mankind Pharma Ltd (NSE: MANKIND | BSE: 543904) shares were trading around ₹2,118.60, up ₹50.40 (2.44%) on March 18, 2026. The stock opened at ₹2,066.80, touched a high of ₹2,123.10, and a low of ₹2,052.00 during the session. The company’s market capitalization is around ₹87,250 crore. Mankind Pharma on Wednesday announced that it has acquired … Read more
